Jubilant Pharmova Allots ₹800 Cr NCDs

Jubilant Pharmova Limited announced the allotment of 80,000 Unsecured, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs) aggregating to ₹800 crore on a private placement basis. The Finance Committee of the company approved the allotment at its meeting held on November 5, 2026. These NCDs have a face value of ₹1,00,000 each, are issued at par, and carry an interest rate of 8.50% per annum. The tenure of the instrument is 3 years, with the maturity date set for November 5, 2028. This move is part of the company's ongoing financing strategy, following a prior disclosure on October 12, 2026.